Plexāā, a medical technology company focused on improving surgical outcomes, has announced the U.S. launch of its BLOOM43 platform, coinciding with Breast Cancer Awareness Month.
The platform combines a wearable preconditioning device and a companion app to help patients prepare for breast surgery.
The BLOOM43 device, worn at home before surgery, uses Supraphysiological Preconditioning™—a technique clinically proven to boost skin resilience, improve blood flow, and reduce wound complications.
Breast surgery carries significant risks, including infections and skin necrosis, which can occur in up to 30% of reconstruction or implant procedures. By preconditioning the skin, BLOOM43 aims to lower these risks and enhance healing.
The device delivers sensor-controlled thermal stimulation to strengthen tissue health, while the BLOOM43 app offers a science-based Prehab™ programme covering nutrition, fitness, and recovery guidance. Together, they provide a holistic approach to pre-surgical preparation.
Clinical studies show Supraphysiological Preconditioning™ can reduce skin necrosis by 24%, halve follow-up surgeries, shorten hospital stays by two days, and lower outpatient visits by 70%.
The BLOOM43 device is now prescribed at select U.S. clinics and available nationally with a prescription, while the app can be downloaded globally on the App Store and Google Play.
This launch marks a major step forward in patient-centred surgical care, empowering individuals to actively improve their outcomes and recovery through evidence-based, at-home preparation.
